-
Integra LifeSciences Announces Multi-Year Agreement With Premier Purchasing Partners to Provide Neurosurgical Products
Thursday, September 1, 2011 - 6:45am | 120Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that it has signed a new multi-year contract with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance, to provide dural repair, neuro trauma (neuro critical care), neuro...
-
STRYKER Signs Definitive Agreement to Acquire CONCENTRIC MEDICAL, Inc.
Wednesday, August 31, 2011 - 4:00pm | 57Concentric Medical, Inc., a global leader in acute ischemic stroke intervention, today announced that Stryker Corporation (NYSE: SYK) has signed a definitive agreement to acquire Concentric Medical for $135 million in an all-cash transaction. The acquisition, pending customary regulatory approvals...
-
FONAR Announces UPRIGHT MRI Sale to Central California Medical Practice Dedicated to Being a Center of Excellence for the Spine
Wednesday, August 31, 2011 - 11:06am | 203FONAR Corporation (NASDAQ: FONR) announced it has sold an UPRIGHT® Multi-Position™ MRI to Bakersfield UPRIGHT MRI Center, Bakersfield, CA. Hoorman M. Melamed, MD, FAOOS, a board certified orthopaedic spine surgeon and a principal at the Bakersfield UPRIGHT MRI Center, said, "Selection of the...
-
Medtronic Starts New U.S. Study of Endurant AAA Stent Graft
Wednesday, August 31, 2011 - 11:01am | 45Leading the development of endovascular aortic repair, Medtronic, Inc. (NYSE: MDT) today announced the start of its U.S. post-approval study of the Endurant AAA Stent Graft System, a medical device used to treat abdominal aortic aneurysms.
-
St. Jude Medical Begins US Trial Studying ST Segment Monitoring Technology
Wednesday, August 31, 2011 - 9:00am | 426St. Jude Medical, Inc. (NYSE: STJ) today announced that the first patient in a clinical study examining the safety and effectiveness of an ST segment monitoring feature in an implantable cardioverter defibrillator has been implanted with the investigational device in the United States. The ST...
-
Baxter Announces FDA Approval of ARTISS Fibrin Sealant for Use in Face-Lift (Facial Rhytidectomy) Procedures
Wednesday, August 31, 2011 - 8:31am | 142Baxter International Inc (NYSE: BAX) announced today that the U.S. Food and Drug Administration has expanded the indication of ARTISS [Fibrin Sealant (Human)] to include adhering tissue flaps during facial rhytidectomy surgery (face-lift). ARTISS is the only premixed, ready-to-use fibrin sealant...
-
ResMed Appoints New COO; Announces $20M Share Buyback
Tuesday, August 30, 2011 - 4:15pm | 84Effective September 1, 2011, ResMed (NYSE: RMD) has appointed Robert Douglas, age 51, as a chief operating officer. Mr. Douglas will serve, together with the chairman and chief executive officer, Peter C. Farrell, PhD., in a newly-formed “office of the chief executive officer,” with full...
-
Benzinga's Volume Movers
Tuesday, August 30, 2011 - 10:25am | 165OmniVision Technologies Inc (NASDAQ: OVTI) shares moved up 4.52% to $18.05 at 10:20 am. The volume of OVTI shares traded was 164% higher than normal. OVTI's trailing-twelve-month revenue is $1.04 billion. Monro Muffler Brake Inc (NASDAQ: MNRO) shares rose 3.88% to $40.93. The volume of MNRO...
-
Citi Maintains Hold on Zimmer Holdings
Tuesday, August 30, 2011 - 9:58am | 103Citi is out with its report today on Zimmer Holdings (NYSE: ZMH), maintaining Hold. In its report, Citi writes, "We rate Zimmer Holdings Hold/Medium Risk. Fundamentals underlying the recon industry remain weak with the current economic environment causing a delay in some procedures. While Zimmer...
-
Citi Maintains Hold on Stryker
Tuesday, August 30, 2011 - 9:54am | 75Citi is out with its report today on Stryker (NYSE: SYK), maintaining Hold. In its report, Citi writes, "We rate Stryker Hold/Medium Risk. Fundamentals underlying the hip, knee, and spine implant markets remain soft with the current economic environment still causing postponement of elective...
-
Citi Maintains Buy on Medtronic
Tuesday, August 30, 2011 - 9:50am | 110Citi is out with its report today on Medtronic (NYSE: MDT), maintaining Buy. In its report, Citi writes, "We rate the shares of Medtronic Buy/Medium Risk (1M). Medtronic's relative price-to-earnings (P/E) multiple to its large-cap med tech peers is at a 20% discount, versus a ten-year average of a...
-
Citi Maintains Buy on Covidien
Tuesday, August 30, 2011 - 9:18am | 82Citi is out with its report today on Covidien (NYSE: COV), maintaining Buy. In its report, Citi writes, "We rate shares of Covidien (COV) Buy/Medium Risk (1M). Further visibility into improving leverage along with continued execution among broadly discussed strategic activities should enhance the...
-
Stereotaxis' Board of Directors Reaffirms Commercialization Plans for Epoch and Odyssey Product Platforms
Tuesday, August 30, 2011 - 7:28am | 198The Board of Directors of Stereotaxis, Inc. (NASDAQ: STXS) announced today following its regularly scheduled board meeting that it reaffirmed the Company's plans for both the launch of the Epoch™ platform and expansion of the Odyssey™ platform into standard labs. "At our meeting last week, the...
-
Earnings Scheduled For August 30
Tuesday, August 30, 2011 - 3:47am | 289Barnes & Noble Inc (NYSE: BKS) is expected to report a FQ1 loss at $0.94 per share. Dollar General Corporation (NYSE: DG) is estimated to report its Q2 EPS at $0.48 on sales of $3.54 billion. The Bank Of Nova Scotia (NYSE: BNS) is projected to report its Q3 EPS at $1.13 on revenue of $4.33...
-
BIOLASE Granted Canadian Approval to Sell Waterlase iPlus All-Tissue Dental Laser Systems
Monday, August 29, 2011 - 9:02am | 57BIOLASE Technology, Inc. (NASDAQ: BLTI) today announced that it has received approval from the Health Canada-Medical Device Bureau to sell its Waterlase iPlus™ all-tissue dental laser systems throughout Canada. Canada has an estimated 19,000 licensed dentists. BIOLASE sells its products in Canada...